Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy

Seroclearance of hepatitis B surface antigen (HBsAg) (“functional cure”) is the optimal endpoint of antiviral therapy for chronic hepatitis B virus (HBV) infection. Currently available anti-HBV therapy includes nucleoside/nucleotide analogs (NAs) and peginterferon-α (Peg-IFNα). Combination of NAs an...

Full description

Bibliographic Details
Main Authors: Kanako Yoshida, Masaru Enomoto, Akihiro Tamori, Shuhei Nishiguchi, Norifumi Kawada
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
chronic hepatitis B
ETV
HBsAg
HBV
peginterferon-α
TDF
Online Access:https://www.mdpi.com/1422-0067/22/3/1456

Internet

https://www.mdpi.com/1422-0067/22/3/1456

Similar Items